Treatment of Idiopathic Thrombocytopenic Purpura (ITP) With Subcutaneously Administered Anti-D

PHASE2CompletedINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

November 30, 2004

Primary Completion Date

January 31, 2008

Study Completion Date

December 31, 2008

Conditions
Idiopathic Thrombocytopenic Purpura
Interventions
DRUG

Anti-D

Subcutaneous injection

Trial Locations (17)

2100

Rigshospitalet, Copenhagen University Hospital, Pediatric Clinic II, Copenhagen Ø

2300

Amager Hospital, Department of Pediatrics, Copenhagen S

2650

Hvidovre Hospital, Department of Pediatrics, Hvidovre

2900

Gentofte Hospital, Department of Pediatrics, Gentofte Municipality

4300

Holbæk Hospital, Department of Pediatrics, Holbæk

4700

Næstved Hospital, Department of Pediatrics, Næstved

4800

Nykøbing F, Department of Pediatrics, Nykøbing Falster

5000

Odense University Hospital, Odense C

6000

Kolding Hospital Department of Pediatrics, Kolding

6400

Sønderborg Hospital, Department of Pediatrics, Sønderborg

6700

Esbjerg Hospital, Department of Pediatrics, Esbjerg

7400

Herning Hospital, Department of Pediatrics, Herning

8200

Skejby Hospital, Aarhus University Hospital, Department of Pediatrics, Aarhus N

8800

Viborg Hospital, Department of Pediatrics, Viborg

8900

Randers Hospital, Department of Pediatrics, Randers

9100

Aalborg University Hospital, Department of Pediatrics, Aalborg

9800

Hjoerring Hospital, Department of Pediatrics, Hjørring

All Listed Sponsors
collaborator

Kjaersgaard, Mimi, M.D.

INDIV

lead

University of Aarhus

OTHER

NCT00128882 - Treatment of Idiopathic Thrombocytopenic Purpura (ITP) With Subcutaneously Administered Anti-D | Biotech Hunter | Biotech Hunter